Budget 2013: pharma ‘pleased’
March 21, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Budget, Osborne, UK
Pharma and health bodies have broadly given George Osborne’s Budget a warm welcome, with cuts in corporation tax, increased R&D …
Targacept makes changes to Board and management
March 21, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Targacept
Clinical-stage biopharma firm Targacept has announced several changes to its Board of directors and management. By the end of May …
Underwhelming results for Victoza
March 20, 2013Sales and Marketing Novo Nordisk, Victoza, diabetes
Novo Nordisk has reported underwhelming results for a well-established diabetes treatment in a late-stage trial designed to test its weight …
MPs: NHS must be ‘re-imagined’
March 20, 2013Sales and Marketing Dorrell, NHS
Increasing cost pressure on the NHS will lead to a breakdown in health and social care services unless commissioning becomes …
Ziarco appoints John LaMattina as R&D advisor
March 20, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing LaMattina, Ziarco
Ex-global head of Pfizer R&D and Pharmafocus regular John LaMattina has been given a strategic advisory role by biotech firm …
Knee trial for Merck KGaA
March 19, 2013Research and Development, Sales and Marketing Merck KGaA, knee, nordic
Merck KGaA is to begin a Phase IIb trial of its investigational drug sprifermin in patients with osteoarthritis (OA) of …
AstraZeneca restructures global R&D
March 19, 2013Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, R&D
AstraZeneca is restructuring its global operations in a bid to improve the productivity of its R&D operations. The firm is …
New associate director for PAN
March 19, 2013Medical Communications, Sales and Marketing Pan
Creative comms agency PAN has announced that Sarah Verhoeff has joined the firm from Havas Life as an associate director.Verhoeff …
ECHA examines safety of cobalt salts used in pharma manufacturing
March 19, 2013Manufacturing and Production ECHA, cobalt
The European Chemicals Agency (ECHA) is looking into the safety of five cobalt salts that have applications in pharmaceutical manufacturing. …
EU publishes final GDP guidelines
March 19, 2013Manufacturing and Production EC, EU, GDP
The European Commission has published the final version of its long-awaited guidelines on Good Distribution Practice (GDP), replacing an earlier …
Hunt: ‘Listen to patients’
March 18, 2013Sales and Marketing Hunt, NHS
A review of NHS complaints handling, aimed at ensuring that all hospitals listen to and act upon the concerns of …
Doctors body joins AllTrials
March 18, 2013Medical Communications, Sales and Marketing alltrials, faculty
The Faculty of Pharmaceutical Medicine has signed up to AllTrials in the latest boost for the campaign for greater trial …
Britannia Pharma appoints marketing director
March 18, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing britannia
Britannia Pharmaceuticals (part of the STADA Arzneimittel group of companies) has appointed Robert Wood as marketing director, for international markets. …
GSK’s Witty: ‘Drugs should be cheaper’
March 15, 2013Manufacturing and Production, Research and Development, Sales and Marketing ABPI, GSK, Witty
Drugs should be cheaper, GlaxoSmithKline boss Sir Andrew Witty said at a conference this week. His comments, reported by Reuters, …
BASF makes organisational changes
March 15, 2013Manufacturing and Production, Research and Development, Sales and Marketing BASF
Leading chemical firm BASF has made a series of appointments in order to reorganise its business operations. Strengthening the Asia-Pacific …
Pulse mistake costs Astellas
March 15, 2013Medical Communications, Sales and Marketing ABPI, Astellas, PMCPA, pulse
A mistake by medical journal Pulse has landed Astellas Pharma in hot water with the PMCPA, enforcers of the ABPI …
Merck makes Alzheimer’s deal
March 14, 2013Research and Development, Sales and Marketing Alzheimer's, Merck
Merck is teaming up with Texas-based Luminex Corporation to develop a companion diagnostic to help in its dementia programme. The …
J&J opens London hub
March 14, 2013Medical Communications, Research and Development, Sales and Marketing J&J, JJ, London, research
Johnson & Johnson has opened the doors to a new life sciences centre in London that forms part of a …
MHRA wins data scam case
March 13, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Aptuit, MHRA, data
An ex-employee of research organisation Aptuit has been found guilty of changing pre-clinical trial data as part of a bid to …
AbbVie guards Humira data
March 13, 2013Sales and Marketing AbbVie, Abbott, Humira, RA, transparency
AbbVie has issued two injunctions against the European Medicines Agency to prevent the regulator revealing data about rheumatoid arthritis drug …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
